SCHEMBL15711835

SCHEMBL15711835

COc1cccc(CO)c1-c1ccccc1[P@](C)(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.47
▸ KMT2A Q03164 5/20 0.47
▸ HTT P42858 2/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ ELANE P08246 1/20 0.39
▸ PDCD1 Q15116 2/20 0.38
▸ CD274 Q9NZQ7 2/20 0.38
▸ CTSA P10619 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA7 P43166 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ ALDH1A1 P00352 5/20 0.37
▸ MAPT P10636 3/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ TOP1 P11387 1/20 0.37
▸ EGFR P00533 1/20 0.37
▸ PIM1 P11309 1/20 0.37
▸ FABP7 O15540 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15711847 0.89 KMT2A (0.47) MEN1KMT2AHTTL3MBTL1ELANE
SCHEMBL19189841 0.87 MEN1 (0.51) MEN1KMT2AHTTL3MBTL1ELANE
SCHEMBL18315874 0.80 APP (0.47) MEN1KMT2AL3MBTL1ELANEPDCD1
SCHEMBL12808219 0.79 MEN1 (0.44) MEN1KMT2AL3MBTL1ELANEPDCD1
SCHEMBL15674146 0.76 MEN1 (0.52) MEN1KMT2AHTTL3MBTL1ELANE
SCHEMBL16572260 0.76 PDCD1 (0.47) MEN1KMT2AELANEPDCD1CD274
SCHEMBL15715568 0.76 MEN1 (0.56) MEN1KMT2AHTTL3MBTL1ELANE
SCHEMBL23658965 0.75 KMT2A (0.60) MEN1KMT2AHTTL3MBTL1CA1
SCHEMBL4924251 0.75 KMT2A (0.60) MEN1KMT2AHTTL3MBTL1CA1
SCHEMBL3791443 0.75 KMT2A (0.60) MEN1KMT2AHTTL3MBTL1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8816112-B2 Process for making novel chiral phosphorus ligands BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-08-26 — — US disclosed
US-20140135506-A1 PROCESS FOR MAKING NOVEL CHIRAL PHOSPHORUS LIGANDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140135506-A1 PROCESS FOR MAKING NOVEL CHIRAL PHOSPHORUS LIGANDS PHOSPHO1, INPP5B, PLCG2 MEN1 1250/4885KMT2A 3508/4885HTT 4612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback